Updates & Interim Data of mRNA-Based Cancer Vaccines to Treat EBV-Related Cancers

Time: 9:00 am
day: Day One AM


  • Present breakthroughs in the treatment of EBV-related cancers, including NPC and NKT lymphoma
  • Highlight safety and efficacy based on ongoing enrollment and interim data
  • Demonstrate the transformative potential of mRNA therapeutics in the treatment of viral-related malignancies